Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-05-08 Pelzer Robert Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2017-05-08 LEVITT DANIEL J Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2017-05-08 Bridger Gary Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2017-05-08 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Option (right to buy) +36,000 36,000
2017-03-08 Troupin Barbara Chief Medical Officer Grant or award · Stock Option (Right to Buy) +40,000 40,000
2017-03-08 Mitchell David Chilton VP Global Regulatory & Quality Grant or award · Stock Option (Right to Buy) +25,000 25,000
2017-03-08 McCloskey Shelley VP, HR and Administration Grant or award · Stock Option (Right to Buy) +30,000 30,000
2017-03-08 Main David President and CEO Grant or award · Stock Option (Right to Buy) +185,000 185,000
2017-03-08 MacKenzie Lloyd VP Technical Operations Grant or award · Stock Option (Right to Buy) +50,000 50,000
2017-03-08 Jenkins Abigail Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2017-03-08 Alam Kamran CFO, Vice President Finance Grant or award · Stock Option (Right to Buy) +80,000 80,000
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +603 $16.74 $10K 1,132,228
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +5,697 $16.74 $95K 9,410,164
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +1,195 $15.32 $18K 1,133,423
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +11,305 $15.32 $173K 9,421,469
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +258 $16.85 $4K 1,133,681
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +2,442 $16.85 $41K 9,423,911
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +917 $15.35 $14K 1,134,598
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +8,671 $15.35 $133K 9,432,582
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +967 $16.20 $16K 1,135,565

Page 15 of 20 · 397 trades